Details
| Stereochemistry | UNKNOWN |
| Molecular Formula | C27H33N3OS |
| Molecular Weight | 447.635 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 0 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)C1CCC(C)CC1NC(=O)C2=NN(CC3=CC=C(C)C=C3)C4=C2CC5=C4SC=C5
InChI
InChIKey=WUNMBICZGWWVBY-UHFFFAOYSA-N
InChI=1S/C27H33N3OS/c1-16(2)21-10-7-18(4)13-23(21)28-27(31)24-22-14-20-11-12-32-26(20)25(22)30(29-24)15-19-8-5-17(3)6-9-19/h5-6,8-9,11-12,16,18,21,23H,7,10,13-15H2,1-4H3,(H,28,31)
| Molecular Formula | C27H33N3OS |
| Molecular Weight | 447.635 |
| Charge | 0 |
| Count |
|
| Stereochemistry | MIXED |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 3 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 23:21:53 GMT 2025
by
admin
on
Mon Mar 31 23:21:53 GMT 2025
|
| Record UNII |
P6H2AAY2GE
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-NESS-040C5
Created by
admin on Mon Mar 31 23:21:53 GMT 2025 , Edited by admin on Mon Mar 31 23:21:53 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID201010004
Created by
admin on Mon Mar 31 23:21:53 GMT 2025 , Edited by admin on Mon Mar 31 23:21:53 GMT 2025
|
PRIMARY | |||
|
NESS-040C5
Created by
admin on Mon Mar 31 23:21:53 GMT 2025 , Edited by admin on Mon Mar 31 23:21:53 GMT 2025
|
PRIMARY | |||
|
P6H2AAY2GE
Created by
admin on Mon Mar 31 23:21:53 GMT 2025 , Edited by admin on Mon Mar 31 23:21:53 GMT 2025
|
PRIMARY | |||
|
1445751-90-5
Created by
admin on Mon Mar 31 23:21:53 GMT 2025 , Edited by admin on Mon Mar 31 23:21:53 GMT 2025
|
PRIMARY | |||
|
138402821
Created by
admin on Mon Mar 31 23:21:53 GMT 2025 , Edited by admin on Mon Mar 31 23:21:53 GMT 2025
|
PRIMARY | |||
|
NESS-040C5
Created by
admin on Mon Mar 31 23:21:53 GMT 2025 , Edited by admin on Mon Mar 31 23:21:53 GMT 2025
|
PRIMARY | NESS-040C5 is a potent cannabinoid agonist which was developed for the treatment of glaucoma. It has reasonable selectivity for the CB2 receptor subtype, having a CB2 affinity of 0.4nM, and 25x selectivity over the related CB1 receptor. |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> AGONIST |
Ki
|
||
|
TARGET -> AGONIST |
Ki
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
Prepared as a possible agent for the treatment of glaucoma
|